April 13, 2021 |
Brazilian healthcare company Hapvida said Sunday it received board approval for a follow-on equity offering worth up to BRL2.68 billion ($469 million) to finance the acquisition of Notre Dame Intermédica and other deals.
Hapvida will offer 100 million common shares in a primary offering and shareholders will sell 33.3 million in a secondary offering. Both offerings can be increased by 35%, or 35 million shares in the primary offering and 11.7 million in the second offering, the company said in a
Brazilian healthcare company could move up to $469 mln in a follow-on offering to fund the Intermédica acquisition and other deals